PPARG Gene Obesity severe Genetic Test
At DNA Labs UAE, we offer the PPARG Gene Obesity severe Genetic Test to help diagnose individuals with a genetic predisposition to severe obesity. This test analyzes the PPARG gene, which is responsible for regulating glucose and lipid metabolism, as well as adipocyte differentiation.
Test Components and Price
- Test Name: PPARG Gene Obesity severe Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the PPARG Gene Obesity severe Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the PPARG Gene Obesity.
Test Details
The PPARG gene encodes a protein called peroxisome proliferator-activated receptor gamma, which plays a crucial role in regulating glucose and lipid metabolism, as well as adipocyte differentiation. Mutations or variations in the PPARG gene can lead to dysregulation of these processes and are associated with obesity.
NGS (Next-Generation Sequencing) genetic testing is used to analyze multiple genes simultaneously and identify genetic variations or mutations. In the context of severe obesity, NGS genetic testing can identify mutations or variations in the PPARG gene that may contribute to the development of obesity.
NGS genetic testing involves obtaining a DNA sample from the individual, which can be done through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify variations or mutations in the PPARG gene. These variations can range from single nucleotide changes (SNPs) to larger deletions or insertions in the gene sequence.
Once the genetic variations or mutations in the PPARG gene are identified, the results can be interpreted by a genetic counselor or healthcare provider. They can provide information on the potential impact of these variations on the individual’s metabolism and obesity risk.
This information can be used to guide personalized treatment plans, including lifestyle modifications, dietary interventions, and potentially targeted therapies. However, it is important to note that while genetic variations in the PPARG gene can contribute to obesity, they are not the sole cause of the condition. Obesity is a complex disorder influenced by a combination of genetic, environmental, and lifestyle factors.
Therefore, NGS genetic testing for the PPARG gene should be considered as part of a comprehensive evaluation and management plan for severe obesity, rather than a standalone diagnostic tool.
| Test Name | PPARG Gene Obesity severe Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PPARG Gene Obesity, severe NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PPARG Gene Obesity, severe NGS Genetic DNA Test gene PPARG |
| Test Details | The PPARG gene is responsible for encoding a protein called peroxisome proliferator-activated receptor gamma. This protein plays a crucial role in regulating glucose and lipid metabolism, as well as adipocyte differentiation (the process by which preadipocytes develop into mature fat cells). Mutations or variations in the PPARG gene can lead to dysregulation of these processes and are associated with obesity. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify genetic variations or mutations. In the context of severe obesity, NGS genetic testing can be used to identify mutations or variations in the PPARG gene that may contribute to the development of obesity. This type of testing can help in diagnosing individuals with a genetic predisposition to severe obesity and may provide valuable information for personalized treatment and management strategies. NGS genetic testing typically involves obtaining a DNA sample from the individual, which can be done through a blood or saliva sample. The DNA is then sequenced using NGS technology, which allows for the identification of variations or mutations in the PPARG gene. These variations can range from single nucleotide changes (SNPs) to larger deletions or insertions in the gene sequence. Once the genetic variations or mutations in the PPARG gene are identified, the results can be interpreted by a genetic counselor or healthcare provider. They can provide information on the potential impact of these variations on the individual’s metabolism and obesity risk. This information can be used to guide personalized treatment plans, including lifestyle modifications, dietary interventions, and potentially targeted therapies. It is important to note that while genetic variations in the PPARG gene can contribute to obesity, they are not the sole cause of the condition. Obesity is a complex disorder influenced by a combination of genetic, environmental, and lifestyle factors. Therefore, NGS genetic testing for the PPARG gene should be considered as part of a comprehensive evaluation and management plan for severe obesity, rather than a standalone diagnostic tool. |
